trending Market Intelligence /marketintelligence/en/news-insights/trending/K9rM58uI6W8Y0fpdTmy0Fw2 content esgSubNav
In This List

SC Farmaceutica REMEDIA Q3 profit climbs 15.5% YOY

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains

Blog

Insight Weekly: M&A slows down; climate tops proxy season; private equity pours into blockchain


SC Farmaceutica REMEDIA Q3 profit climbs 15.5% YOY

Farmaceutica REMEDIA S.A. said its normalized net income for the third quarter was 193,890 lei, an increase of 15.5% from 167,900 lei in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin fell to 0.1% from 0.3% in the year-earlier period.

Total revenue rose 8.1% on an annual basis to 66.9 million lei from 61.9 million lei, and total operating expenses grew 6.9% on an annual basis to 66.9 million lei from 62.6 million lei.

Reported net income came to 78,910 lei, compared with 376,460 lei, or 0 bani per share, in the prior-year period.

As of Nov. 15, US$1 was equivalent to 4.21 Romanian lei.